HYA Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$343K Buy
10,699
+69
+0.6% +$2.54K 0.13% 104
2022
Q1
$335K Buy
10,630
+98
+0.9% +$3.06K 0.12% 120
2021
Q4
$353K Buy
10,532
+82
+0.8% +$2.55K 0.13% 118
2021
Q3
$328K Buy
10,450
+82
+0.8% +$2.65K 0.13% 119
2021
Q2
$361K Buy
10,368
+69
+0.7% +$2.29K 0.15% 106
2021
Q1
$287K Buy
10,299
+93
+0.9% +$2.48K 0.14% 111
2020
Q4
$253K Buy
10,206
+96
+0.9% +$2.28K 0.13% 111
2020
Q3
$211K Buy
+10,110
New +$195K 0.13% 116

Other funds holding CC

HYA Advisors's CC Position: Q2 2022 in Review

HYA Advisors increased its Chemours (CC) stake by 0.65% in Q2 2022, buying an estimated $2.54K and bringing the position to 10,699 shares worth $343K. The position accounts for 0.13% of the portfolio, ranked #104.

HYA Advisors first reported a position in CC in Q3 2020 and has held it in 8 quarters since. The position peaked at $361K in Q2 2021. 517 funds tracked by Wall St. Rank hold CC as of Q2 2022.

  • HYA Advisors held 10,699 shares of Chemours worth $343K as of Q2 2022.
  • HYA Advisors bought 69 Chemours shares in Q2 2022, an estimated $2.54K.
  • Chemours made up 0.13% of HYA Advisors's portfolio in Q2 2022, its #104 holding.
  • HYA Advisors first reported a position in Chemours in Q3 2020 and has held it in 8 quarters since.
  • HYA Advisors's Chemours position peaked at $361K in Q2 2021.
  • 517 funds tracked by Wall St. Rank held Chemours as of Q2 2022.

Based on HYA Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.